These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12101625)

  • 1. [Can the society afford not to subsidize smoking cessation?].
    Larsson M; Larsson K; Gilljam H; Curman B
    Lakartidningen; 2002 Jun; 99(23):2665-6. PubMed ID: 12101625
    [No Abstract]   [Full Text] [Related]  

  • 2. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion for smokers. Where are practices supposed to find money for bupropion?
    Vautrey R
    BMJ; 2001 Feb; 322(7283):432-3. PubMed ID: 11179167
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
    Shanahan M; Doran C; Gates J; Shakeshaft A; Mattick RP
    Appl Health Econ Health Policy; 2003; 2(2):76-8. PubMed ID: 14619277
    [No Abstract]   [Full Text] [Related]  

  • 5. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
    Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
    Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does insurance coverage for drug therapy affect smoking cessation?
    Boyle RG; Solberg LI; Magnan S; Davidson G; Alesci NL
    Health Aff (Millwood); 2002; 21(6):162-8. PubMed ID: 12442851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
    Woolacott NF; Jones L; Forbes CA; Mather LC; Sowden AJ; Song FJ; Raftery JP; Aveyard PN; Hyde CJ; Barton PM
    Health Technol Assess; 2002; 6(16):1-245. PubMed ID: 12269277
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
    Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N
    Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
    Hill A
    Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560
    [No Abstract]   [Full Text] [Related]  

  • 13. Smoking cessation therapy considerations for patients with chronic kidney disease.
    Manley HJ; Stack NM
    Nephrol Nurs J; 2008; 35(4):357-63, 394; quiz 364. PubMed ID: 18782998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of pharmacotherapy products in smoking cessation.
    Percival J
    Prof Nurse; 2003 Oct; 19(2):113-7. PubMed ID: 14593787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion for smokers. New products for smoking cessation maintain profile of smoking cessation services.
    Richardson W
    BMJ; 2001 Feb; 322(7283):432; discussuion 432-3. PubMed ID: 11179164
    [No Abstract]   [Full Text] [Related]  

  • 16. Buproprion, public funding, and smoking cessation.
    Bloomfield A
    N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity in preferences for smoking cessation.
    Paterson RW; Boyle KJ; Parmeter CF; Neumann JE; De Civita P
    Health Econ; 2008 Dec; 17(12):1363-77. PubMed ID: 18189227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bupropion as an aid for smoking cessation].
    Tonstad S
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2612-5. PubMed ID: 12523190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zyban in smoking cessation].
    Flaten O
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):507-8. PubMed ID: 11255877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.